Press Releases
April 18th, 2023
Stilla Technologies adds 20 new liquid biopsy kits to its reagents portfolio from partner ApexBio
BURLINGTON, MA – Stilla Technologies today announced the availability of 20 new digital PCR assays, optimized for its Crystal Digital…
March 30th, 2023
Stilla Technologies and Atila BioSystems to co-develop high-plex digital PCR kits for onocology
Stilla Technologies and Atila BioSystems today announced an agreement to market digital PCR kits and assays produced by Atila BioSystems…
March 20th, 2023
New Stilla Ruby Chip and naica® system 21 CFR Part 11 compliance enable full automation of digital PCR testing for clinically-oriented applications
BOSTON, MA (March 2, 2023) – Stilla Technologies, the multiplex digital PCR company, has recently introduced the Ruby Chip, the…
August 2nd, 2022
Stilla Technologies solidifies leadership in EMEA, expands footprint in APAC
PARIS & BOSTON–Stilla Technologies, the multiplex digital PCR company, announces the addition of Yvan Sergeant to serve in the capacity…
April 6th, 2022
Stilla and Promega Announce Co-Marketing Agreement to Offer Complete Digital PCR Workflow Solution
BOSTON–Stilla Technologies, the multiplex digital PCR company, and Promega Corporation today announced a co-marketing agreement that combines sample preparation with…
March 22nd, 2022
Stilla Technologies Expands EMEA Footprint with New Distribution Partnerships
BOSTON & PARIS–(BUSINESS WIRE)–Stilla Technologies, the multiplex digital PCR company, today announced it has entered into agreements with 12 distributors…
November 23rd, 2021
Stilla Technologies Secures Financing of More Than €31 Million Adding Casdin Capital and the European Investment Bank to Existing Investors
PARIS & BOSTON–(BUSINESS WIRE)–Stilla Technologies, the multiplex digital PCR company, today announced it has raised €31.3 million in the form…
November 4th, 2021
Leading Researchers Present 24-Plex Digital PCR Assay and Novel Multiplex Applications Uniquely Enabled by Stilla’s 6-Color naica® system
Industry’s First 6-Color Digital PCR System Answers Market Needs for Higher Performance and Multiplexing Technology BOSTON and PARIS, October 15,…
July 28th, 2021
Stilla Technologies Launches Access Program for Industry’s First Six-Color Digital PCR System
New dPCR Platform Offers High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious…
June 30th, 2021
Stilla Technologies Strengthens Executive Team with Appointment of Matthew Grow, PhD, to Vice President Global Marketing and Commercial Operations
Life Sciences Veteran to Lead Commercialization of Disruptive Digital PCR Technology for a Broad Range of Basic Research and Clinical…